Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0YU3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,713
Award facts
- Contract value 100% obligated
- $52,713.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $52,713.35 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on December 22, 2025, with completion scheduled for December 23, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be performed and supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive portfolio of medications and medical supplies to support military healthcare systems and the Defense Health Agency. Dupixent (dupilumab) is a specialty biologic medication used primarily for treating moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps. This delivery order fulfills medical supply requirements under the broader pharmaceutical prime vendor global program, enabling AmerisourceBergen to serve military and veteran healthcare systems with specialized pharmaceutical commodities on a cost-effective, firm fixed-price basis.
Quick answers
Who was awarded contract SPE2DR26F0YU3?
SPE2DR26F0YU3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F0YU3 worth?
The government has obligated $52,713 on SPE2DR26F0YU3.
Is contract SPE2DR26F0YU3 an order under another contract?
Yes. SPE2DR26F0YU3 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0YU3 competed?
The extent of competition for SPE2DR26F0YU3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award